Get the Stockscreener App
1.50
0.67%
0.01
Alector Inc stock is traded at $1.50, with a volume of 362.91K.
It is up +0.67% in the last 24 hours and up +20.97% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.49
Open:
$1.48
24h Volume:
362.91K
Relative Volume:
0.43
Market Cap:
$158.99M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.2195
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
+2.74%
1M Performance:
+20.97%
6M Performance:
-17.58%
1Y Performance:
-65.28%
1-Day Range:
$1.43
$1.505
1-Week Range:
$1.355
$1.535
52-Week Range:
$0.87
$6.78
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.50 | 158.99M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.40 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.25 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.04 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector appoints Neil Berkley as interim CFO - MSN
Alector (ALEC) Appoints Interim CFO as Current CFO Departs | ALE - GuruFocus
Alector Provides Executive Leadership Update | ALEC Stock News - GuruFocus
Alector, Inc. (NASDAQ:ALEC) Given Consensus Rating of “Hold” by Brokerages - Defense World
Alector Names Neil Berkley as Interim CFO - MarketScreener
Alector Provides Executive Leadership Update - GlobeNewswire
Alector, Inc. (NASDAQ:ALEC) Position Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Alector shares surge 73% following InvestingPro’s April fair value signal By Investing.com - Investing.com Australia
Cantor Fitzgerald Forecasts Alector FY2026 Earnings - Defense World
Transcript : Alector, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Nuveen Asset Management LLC - Defense World
Alector president sells shares worth $31,974 - Investing.com Australia
Alector president sells shares worth $31,974 By Investing.com - Investing.com Canada
Alector Executives Sell Shares to Cover Tax Obligations - TradingView
Are Investors Inclined To Sell Their Alector Inc (NASDAQ: ALEC) Holdings? - Stocksregister
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
Goldman Sachs Conference: Alector Reveals Next Steps in Fighting NeurodegenerationKey Updates Coming - Stock Titan
Alzheimer's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com
BNP Paribas Financial Markets Grows Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Northern Trust Corp Purchases 40,291 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
D. E. Shaw & Co. Inc. Raises Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Deutsche Bank AG Reduces Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target - BioSpace
Sanofi Makes Alzheimer’s Bet With Vigil Buy - insights.citeline.com
Top Penny Stocks To Watch In May 2025 - simplywall.st
What Did We Note About Insider Trading At Alector Inc (NASDAQ: ALEC)? - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Dimensional Fund Advisors LP Raises Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector at BofA Securities 2025 Healthcare Conference: Strategic Innovations in Brain Disorder Therapies - Investing.com
Alector Reports Increased Loss, Advances Clinical Pipeline - TipRanks
Alector stock price target raised to $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Alector stock price target raised to $10 at H.C. Wainwright - Investing.com
Alector (ALEC) to Release Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.26 - Yahoo Finance
US$5.26That's What Analysts Think Alector, Inc. (NASDAQ:ALEC) Is Worth After These Results - simplywall.st
Alector (ALEC) Maintains Buy Rating as Price Target Increases | - GuruFocus
Alector First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Sto - GuruFocus
Alector (ALEC) Maintains Buy Rating as Price Target Increases | ALEC Stock News - GuruFocus
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Stock News - GuruFocus
Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Alector Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Alector (ALEC) Reports Q1 Revenue Shortfall, Advances Drug Trials | ALEC Stock News - GuruFocus
Alector reports Q1 EPS (41c), consensus (46c) - TipRanks
Alector Inc Reports Q1 2025 Earnings: EPS Loss of $0.41 Beats Estimates, Revenue Falls Short at $3.7 Million - GuruFocus
Alector, Inc. SEC 10-Q Report - TradingView
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GRASSO MARC | Chief Financial Officer |
Jun 02 '25 |
Sale |
1.34 |
16,488 |
22,068 |
296,072 |
| Kenkare-Mitra Sara | President and Head of R&D |
Jun 02 '25 |
Sale |
1.34 |
23,890 |
31,974 |
512,252 |
| Rosenthal Arnon | Chief Executive Officer |
Jun 02 '25 |
Sale |
1.34 |
52,087 |
69,713 |
2,414,657 |
1.02%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):